267 related articles for article (PubMed ID: 12089289)
41. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
42. Plants used in Guatemala for the treatment of dermatophytic infections. 2. Evaluation of antifungal activity of seven American plants.
Cáceres A; López B; Juárez X; del Aguila J; García S
J Ethnopharmacol; 1993 Dec; 40(3):207-13. PubMed ID: 8145577
[TBL] [Abstract][Full Text] [Related]
43. Antifungal activity of Aegle marmelos (L.) Correa (Rutaceae) leaf extract on dermatophytes.
Balakumar S; Rajan S; Thirunalasundari T; Jeeva S
Asian Pac J Trop Biomed; 2011 Aug; 1(4):309-12. PubMed ID: 23569781
[TBL] [Abstract][Full Text] [Related]
44. Anti dermatophytic activity of Azardirachta indica (neem) by invitro study.
Natarajan V; Pushkala S; Karuppiah VP; Prasad PV
Indian J Pathol Microbiol; 2002 Jul; 45(3):311-3. PubMed ID: 12785173
[TBL] [Abstract][Full Text] [Related]
45. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
46. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
47. Antifungal activity of lichen compounds against dermatophytes: a review.
Furmanek Ł; Czarnota P; Seaward MRD
J Appl Microbiol; 2019 Aug; 127(2):308-325. PubMed ID: 30664814
[TBL] [Abstract][Full Text] [Related]
48. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
Kauffman CA; Zarins LT
Mycoses; 1999; 42(9-10):539-42. PubMed ID: 10592697
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin.
Fritz P; Beck-Jendroschek V; Brasch J
Med Mycol; 2012 Aug; 50(6):579-84. PubMed ID: 22332906
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
51. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
Uchida K; Hosaka J; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
[TBL] [Abstract][Full Text] [Related]
52. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.
Macura AB
Int J Dermatol; 1993 Jul; 32(7):533-6. PubMed ID: 8340195
[TBL] [Abstract][Full Text] [Related]
53. A Multi-Target Approach toward the Development of Novel Candidates for Antidermatophytic Activity: Ultrastructural Evidence on α-Bisabolol-Treated Microsporum gypseum.
Romagnoli C; Baldisserotto A; Malisardi G; Vicentini CB; Mares D; Andreotti E; Vertuani S; Manfredini S
Molecules; 2015 Jun; 20(7):11765-76. PubMed ID: 26132903
[TBL] [Abstract][Full Text] [Related]
54. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
55. Linalool modulates dermatophyte susceptibility to azole drugs.
Ponte HAS; Lima MIO; Lima EO; Pereira FO
Med Mycol; 2020 Feb; 58(2):272-274. PubMed ID: 31329906
[TBL] [Abstract][Full Text] [Related]
56. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Arikan S; Hasçelik G
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):107-11. PubMed ID: 12088616
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Barros MEDS; Santos DA; Hamdan JS
J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
[TBL] [Abstract][Full Text] [Related]
58. Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes.
Fernández-Torres B; Carrillo-Muñoz A; Ortoneda M; Pujol I; Pastor FJ; Guarro J
Med Mycol; 2003 Apr; 41(2):125-30. PubMed ID: 12964844
[TBL] [Abstract][Full Text] [Related]
59. The anti-dermatophyte activity of Allium hirtifolium Boiss aqueous extract.
Mahboubi M; Kazempour N
J Mycol Med; 2015 Mar; 25(1):e10-4. PubMed ID: 25456419
[TBL] [Abstract][Full Text] [Related]
60. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
da Silva Barros ME; de Assis Santos D; Soares Hamdan J
Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
